The involvement of SOX10 in melanoma immunogenicity has been studied extensively, showing that its loss sensitizes tumor cells to T-cell mediated killing [69], and it is a direct transcription factor for immune molecules such as CEACAM1 [70, 71] and IRF4 [32]. This evidence concerns the gene IRF4 and neoplasm.